Taken together, this study presents a genetic ERBB4 variant as a novel prognostic marker in high-risk early breast cancer and indicates the presence of rare but potentially oncogenic ERBB4 mutations in breast cancer. This evidence concerns the gene ERBB4 and breast carcinoma.